Phase 1 Agitation Clinical Trials
2 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–2 of 2 trials
Completed
Phase 1
A study testing wafers containing different doses of dexmedetomidine in healthy volunteers.
Agitation
iX Biopharma Pty Ltd14 enrolled1 locationACTRN12622000952741
Completed
Phase 1
A placebo and comparator controlled phase 1, safety and tolerability study of 3 ascending doses of INP105 (intranasal OLZ by I231 POD® device).
Acute Agitation in SchizophreniaAcute Agitation in Bipolar I Disorder
Clinical Network Services (CNS) Pty Ltd36 enrolled1 locationACTRN12618000966291